Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of SEK 319.68 million. The enterprise value is 236.68 million.

Market Cap	319.68M
Enterprise Value	236.68M

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Medivir AB has 112.17 million shares outstanding. The number of shares has increased by 84.59% in one year.

Current Share Class	n/a
Shares Outstanding	112.17M
Shares Change (YoY)	+84.59%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	10.55%
Owned by Institutions (%)	41.57%
Float	84.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.99
PB Ratio	2.25
P/TBV Ratio	7.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.02
EV / Sales	33.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.39

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.07.

Current Ratio	1.84
Quick Ratio	1.84
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-133.35

Financial Efficiency

Return on equity (ROE) is -87.81% and return on invested capital (ROIC) is -52.90%.

Return on Equity (ROE)	-87.81%
Return on Assets (ROA)	-40.02%
Return on Invested Capital (ROIC)	-52.90%
Return on Capital Employed (ROCE)	-80.47%
Revenue Per Employee	703,300
Profits Per Employee	-11.69M
Employee Count	10
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.60% in the last 52 weeks. The beta is -0.16, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	-14.60%
50-Day Moving Average	2.83
200-Day Moving Average	2.94
Relative Strength Index (RSI)	47.75
Average Volume (20 Days)	119,362

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of SEK 7.03 million and -116.92 million in losses. Loss per share was -1.13.

Revenue	7.03M
Gross Profit	-90.03M
Operating Income	-121.75M
Pretax Income	-116.92M
Net Income	-116.92M
EBITDA	-121.72M
EBIT	-121.75M
Loss Per Share	-1.13

Full Income Statement

Balance Sheet

The company has 92.50 million in cash and 9.50 million in debt, giving a net cash position of 83.00 million or 0.74 per share.

Cash & Cash Equivalents	92.50M
Total Debt	9.50M
Net Cash	83.00M
Net Cash Per Share	0.74
Equity (Book Value)	141.80M
Book Value Per Share	1.26
Working Capital	44.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -99.37 million and capital expenditures 300,000, giving a free cash flow of -99.07 million.

Operating Cash Flow	-99.37M
Capital Expenditures	300,000
Free Cash Flow	-99.07M
FCF Per Share	-0.88

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,731.17%
Pretax Margin	-1,662.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.59%
Shareholder Yield	-84.59%
Earnings Yield	-36.57%
FCF Yield	-30.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -4.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.37
Piotroski F-Score	n/a